{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"mcleod-neuroacanthocytosis","columns":[{"gene":"","key":"population-df8c3b9fb490dcadcda3","label":"Mcleod syndrome","mondoId":"MONDO:0018945","onsetQualifier":null,"originColumnKey":"MONDO:0018945/OMIM:300842","originalViews":[{"key":"MONDO:0018945/OMIM:300842","label":"Mcleod syndrome","scopeLabel":"OMIM:300842","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01a3acca18beb0d41ff33e82644b0545b65c60002df2b2ec49a7246f12cb6b2f","05a3cf4b0c5246bf957b1de8e00e74055368f6f855ec147a9c20a8cdc53ddb9f","09f888e6892eb263345730c6d9fc32c985443b9f10fa7151781a0b5bc4b0b736","0f51d5e0f2cfefbda194bb1eca65287345ff1de9e7c6456927259a5f70118536","10824f3af0132150b798318dacca88d4123eda6c2988eb3ffd4003f350701faf","13ff50ad47d9a1479a8415c42598532aae272f1ed982324ed5b69d9657d0b18f","15865f04a19117f363deb61dfb6408b377216457eede0e192cbf75eacbfaa96b","15fde7dd52a2f76a53e3290db276ab06b0db02ec47491a36eceb8c464d404bbd","218030eb198fd6ff8ba0e6edefb88b61f52b843f33b69191926886c040550372","2243f9d79b0e1709ac5772da889449cbe8e2b821552b8dbd46252b66e088bd60","246babf6c61b9ad0259c3f4c39da6dfadbba68a30246ea66df659a170a61b2dc","2d48d8e7341c8f5db14d6ec90a684eb6e924a20699f660fb67a4f5546d4a9f8d","311996689cc81da8c49e806cdb07ca47851e622804891f2a4504668c7af8328f","3192b6b5adb0b72f5b1bf0c172ee24350d6c1662038a930b14cb8e1b81fe8302","335085b8a445c9605d29aeb120e07c84614d72f00172070fd1b660f30df239b7","392fe837dd83475b36ad8c94528c9338d1b10bba5bfee275c527ab94be12bad4","565ce09b57627f702de28df491313b66578f97379d70792d493f5e5778142ffc","66924ec29f1427455bddf136552f2fe63e70b9d4f8b544757da1f857aa74a60f","74f5d9c3caa59e4feeae20d441e90bef86b4eafbe0928ba0b08d69c5198ab7f4","7517cb9a70a6198529f74cfb0b136f4c8272d257b9e7ef1eab1c08912ae63691","8347001987aac10de44e8cab4d1248d640ff0d7fd123dea6f178168bd211b2ca","974224728f0be5a0ed78ef8722ba246482e7f76fc1d056ca2bc2384934d2d001","a49ad10561f884df88dfd222a77973b896e3ab0cfd1d46858518684e78ee2b48","add0fa79ab0ebfeaf5a8ecd948fcb0103ccf748bf078db5c4eee826b0869bea4","aeb59f7d89b3957c921ce4d61d788e5ab93afd077d5eaf5953d5d92798edc58e","dbb0ed91892300c40e471e0444c791463e82d7ad63cb7b4679f22157df847848","e7dc5408b9d68d4e6dbd8341e324363a17a680e42de359b3d6ed460a5b17d24f","ebbfd1f8fc9571845369f47510e93d81336f4114bf47fe752185ebe27e2790a3","fd65737b3b4e046db50516f4d015349c0280625a7ef4950329ea34fd973818af"],"recordQualifiers":{},"scopeLabel":"OMIM:300842","sourceIds":["OMIM:300842"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-df8c3b9fb490dcadcda3"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003438","HP:0001927","HP:0000739","HP:0012046","HP:0005110","HP:0001638","HP:0002072"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":21,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":29,"sourceGroups":{"omim":4,"published":25}},"features":[{"hpoId":"HP:0003438","label":"Absent Achilles reflex","primary":true},{"hpoId":"HP:0001927","label":"Acanthocytosis","primary":true},{"hpoId":"HP:0000739","label":"Anxiety","primary":true},{"hpoId":"HP:0012046","label":"Areflexia of upper limbs","primary":true},{"hpoId":"HP:0005110","label":"Atrial fibrillation","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0002072","label":"Chorea","primary":true},{"hpoId":"HP:0000722","label":"Compulsive behaviors","primary":false},{"hpoId":"HP:0020181","label":"Decreased circulating haptoglobin concentration","primary":false},{"hpoId":"HP:0000716","label":"Depression","primary":false},{"hpoId":"HP:0001644","label":"Dilated cardiomyopathy","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0100660","label":"Dyskinesia","primary":false},{"hpoId":"HP:0001332","label":"Dystonia","primary":false},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":false},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0030948","label":"Elevated gamma-glutamyltransferase level","primary":false},{"hpoId":"HP:0002197","label":"Generalized-onset seizure","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0006938","label":"Impaired vibration sensation at ankles","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0007002","label":"Motor axonal neuropathy","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0012075","label":"Personality disorder","primary":false},{"hpoId":"HP:0003201","label":"Rhabdomyolysis","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false}],"ledeHtml":"McLeod neuroacanthocytosis syndrome is primarily a neurological disorder that occurs almost exclusively in boys and men. This disorder affects movement in many parts of the body. People with McLeod neuroacanthocytosis syndrome also have abnormal star-shaped red blood cells (acanthocytosis). This condition is one of a group of disorders called neuroacanthocytoses that involve neurological problems and abnormal red blood cells. McLeod neuroacanthocytosis syndrome affects the brain and spinal cord (central nervous system). Affected individuals have involuntary movements, including jerking motions (chorea), particularly of the arms and legs, and muscle tensing (dystonia) in the face and throat, which can cause grimacing and vocal tics (such as grunting and clicking noises). Dystonia of the tongue can lead to swallowing difficulties. Seizures occur in approximately half of all people with McLeod neuroacanthocytosis syndrome. Individuals with this condition may develop difficulty processing, learning, and remembering information (cognitive impairment). They may also develop psychiatric disorders, such as depression, bipolar disorder, psychosis, or obsessive-compulsive disorder. People with McLeod neuroacanthocytosis syndrome also have problems with their muscles, including muscle weakness (myopathy) and muscle degeneration (atrophy). Sometimes, nerves that connect to muscles atrophy (neurogenic atrophy), leading to loss of muscle mass and impaired movement. Individuals with McLeod neuroacanthocytosis syndrome may also have reduced sensation and weakness in their arms and legs (peripheral neuropathy). Life-threatening heart problems such as irregular heartbeats (arrhythmia) and a weakened and enlarged heart (dilated cardiomyopathy) are common in individuals with this disorder. The signs and symptoms of McLeod neuroacanthocytosis syndrome usually begin in mid-adulthood. Behavioral changes, such as lack of self-restraint, the inability to take care of oneself, anxiety, depression, and changes in personality may be the first signs of this condition. While these behavioral changes are typically not progressive, the movement and muscle problems and intellectual impairments tend to worsen with age.","mondoId":"MONDO:0018945","node":{"canonicalSlug":"mcleod-neuroacanthocytosis","comparisons":[{"documentSha256":"dba72b19df7fcecb86230254b75ee0e68a2817bb798f049ebc843ed83ce35128","key":"legacy-mcleod-neuroacanthocytosis","kind":"legacy","label":"XK-related neurodegenerative disease","memberIds":["MONDO:0018945"],"mondoId":"MONDO:0018945","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/mcleod-neuroacanthocytosis.dba72b19df7fcecb86230254b75ee0e68a2817bb798f049ebc843ed83ce35128.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"McLeod neuroacanthocytosis syndrome","originalSourceId":"ORPHA:59306","paragraphs":["McLeod neuroacanthocytosis syndrome is primarily a neurological disorder that occurs almost exclusively in boys and men. This disorder affects movement in many parts of the body. People with McLeod neuroacanthocytosis syndrome also have abnormal star-shaped red blood cells (acanthocytosis). This condition is one of a group of disorders called neuroacanthocytoses that involve neurological problems and abnormal red blood cells. McLeod neuroacanthocytosis syndrome affects the brain and spinal cord (central nervous system). Affected individuals have involuntary movements, including jerking motions (chorea), particularly of the arms and legs, and muscle tensing (dystonia) in the face and throat, which can cause grimacing and vocal tics (such as grunting and clicking noises). Dystonia of the tongue can lead to swallowing difficulties. Seizures occur in approximately half of all people with McLeod neuroacanthocytosis syndrome. Individuals with this condition may develop difficulty processing, learning, and remembering information (cognitive impairment). They may also develop psychiatric disorders, such as depression, bipolar disorder, psychosis, or obsessive-compulsive disorder. People with McLeod neuroacanthocytosis syndrome also have problems with their muscles, including muscle weakness (myopathy) and muscle degeneration (atrophy). Sometimes, nerves that connect to muscles atrophy (neurogenic atrophy), leading to loss of muscle mass and impaired movement. Individuals with McLeod neuroacanthocytosis syndrome may also have reduced sensation and weakness in their arms and legs (peripheral neuropathy). Life-threatening heart problems such as irregular heartbeats (arrhythmia) and a weakened and enlarged heart (dilated cardiomyopathy) are common in individuals with this disorder. The signs and symptoms of McLeod neuroacanthocytosis syndrome usually begin in mid-adulthood. Behavioral changes, such as lack of self-restraint, the inability to take care of oneself, anxiety, depression, and changes in personality may be the first signs of this condition. While these behavioral changes are typically not progressive, the movement and muscle problems and intellectual impairments tend to worsen with age."],"rawAttribution":"MONDO:0018945","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T16:59:09Z","upstream":"GARD:0010731","url":"https://rarediseases.info.nih.gov/diseases/10731"},"ownColumnKeys":["population-df8c3b9fb490dcadcda3"],"publication":"published","relationships":[{"kind":"parent","label":"neuroacanthocytosis","mondoId":"MONDO:0016987","slug":"neuroacanthocytosis"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/mcleod-neuroacanthocytosis-syndrome"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"01a3acca18beb0d41ff33e82644b0545b65c60002df2b2ec49a7246f12cb6b2f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"5/13","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"05a3cf4b0c5246bf957b1de8e00e74055368f6f855ec147a9c20a8cdc53ddb9f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"22/22","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"09f888e6892eb263345730c6d9fc32c985443b9f10fa7151781a0b5bc4b0b736","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003201","is_excluded":false,"label":"Rhabdomyolysis","onset_id":null,"reference":"OMIM:300842","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"0f51d5e0f2cfefbda194bb1eca65287345ff1de9e7c6456927259a5f70118536","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"4/22","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"10824f3af0132150b798318dacca88d4123eda6c2988eb3ffd4003f350701faf","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"5/12","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"13ff50ad47d9a1479a8415c42598532aae272f1ed982324ed5b69d9657d0b18f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"2/22","hpo_id":"HP:0001644","is_excluded":false,"label":"Dilated cardiomyopathy","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"15865f04a19117f363deb61dfb6408b377216457eede0e192cbf75eacbfaa96b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"13/20","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"15fde7dd52a2f76a53e3290db276ab06b0db02ec47491a36eceb8c464d404bbd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"10/13","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"218030eb198fd6ff8ba0e6edefb88b61f52b843f33b69191926886c040550372","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"10/11","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2243f9d79b0e1709ac5772da889449cbe8e2b821552b8dbd46252b66e088bd60","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"18/20","hpo_id":"HP:0003438","is_excluded":false,"label":"Absent Achilles reflex","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"246babf6c61b9ad0259c3f4c39da6dfadbba68a30246ea66df659a170a61b2dc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"8/21","hpo_id":"HP:0012046","is_excluded":false,"label":"Areflexia of upper limbs","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2d48d8e7341c8f5db14d6ec90a684eb6e924a20699f660fb67a4f5546d4a9f8d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"6/15","hpo_id":"HP:0006938","is_excluded":false,"label":"Impaired vibration sensation at ankles","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"311996689cc81da8c49e806cdb07ca47851e622804891f2a4504668c7af8328f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"6/12","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3192b6b5adb0b72f5b1bf0c172ee24350d6c1662038a930b14cb8e1b81fe8302","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000739","is_excluded":false,"label":"Anxiety","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"335085b8a445c9605d29aeb120e07c84614d72f00172070fd1b660f30df239b7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"4/12","hpo_id":"HP:0030948","is_excluded":false,"label":"Elevated gamma-glutamyltransferase level","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"392fe837dd83475b36ad8c94528c9338d1b10bba5bfee275c527ab94be12bad4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007002","is_excluded":false,"label":"Motor axonal neuropathy","onset_id":null,"reference":"OMIM:300842","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"565ce09b57627f702de28df491313b66578f97379d70792d493f5e5778142ffc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"4/5","hpo_id":"HP:0020181","is_excluded":false,"label":"Decreased circulating haptoglobin concentration","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"66924ec29f1427455bddf136552f2fe63e70b9d4f8b544757da1f857aa74a60f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"18/19","hpo_id":"HP:0002072","is_excluded":false,"label":"Chorea","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"74f5d9c3caa59e4feeae20d441e90bef86b4eafbe0928ba0b08d69c5198ab7f4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"8/10","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7517cb9a70a6198529f74cfb0b136f4c8272d257b9e7ef1eab1c08912ae63691","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"5/13","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8347001987aac10de44e8cab4d1248d640ff0d7fd123dea6f178168bd211b2ca","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002197","is_excluded":false,"label":"Generalized-onset seizure","onset_id":null,"reference":"OMIM:300842","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"974224728f0be5a0ed78ef8722ba246482e7f76fc1d056ca2bc2384934d2d001","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0100660","is_excluded":false,"label":"Dyskinesia","onset_id":null,"reference":"OMIM:300842","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a49ad10561f884df88dfd222a77973b896e3ab0cfd1d46858518684e78ee2b48","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012075","is_excluded":false,"label":"Personality disorder","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"add0fa79ab0ebfeaf5a8ecd948fcb0103ccf748bf078db5c4eee826b0869bea4","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"5/22","hpo_id":"HP:0005110","is_excluded":false,"label":"Atrial fibrillation","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aeb59f7d89b3957c921ce4d61d788e5ab93afd077d5eaf5953d5d92798edc58e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"5/15","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"dbb0ed91892300c40e471e0444c791463e82d7ad63cb7b4679f22157df847848","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"e7dc5408b9d68d4e6dbd8341e324363a17a680e42de359b3d6ed460a5b17d24f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000722","is_excluded":false,"label":"Compulsive behaviors","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ebbfd1f8fc9571845369f47510e93d81336f4114bf47fe752185ebe27e2790a3","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"22/22","hpo_id":"HP:0001927","is_excluded":false,"label":"Acanthocytosis","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fd65737b3b4e046db50516f4d015349c0280625a7ef4950329ea34fd973818af","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:300842","disease_name":"Mcleod syndrome","evidence":"PCS","frequency_raw":"5/15","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:11761473","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10731\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018945\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010731</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>McLeod neuroacanthocytosis syndrome is primarily a neurological disorder that occurs almost exclusively in boys and men. This disorder affects movement in many parts of the body. People with McLeod neuroacanthocytosis syndrome also have abnormal star-shaped red blood cells (acanthocytosis). This condition is one of a group of disorders called neuroacanthocytoses that involve neurological problems and abnormal red blood cells. McLeod neuroacanthocytosis syndrome affects the brain and spinal cord (central nervous system). Affected individuals have involuntary movements, including jerking motions (chorea), particularly of the arms and legs, and muscle tensing (dystonia) in the face and throat, which can cause grimacing and vocal tics (such as grunting and clicking noises). Dystonia of the tongue can lead to swallowing difficulties. Seizures occur in approximately half of all people with McLeod neuroacanthocytosis syndrome. Individuals with this condition may develop difficulty processing, learning, and remembering information (cognitive impairment). They may also develop psychiatric disorders, such as depression, bipolar disorder, psychosis, or obsessive-compulsive disorder. People with McLeod neuroacanthocytosis syndrome also have problems with their muscles, including muscle weakness (myopathy) and muscle degeneration (atrophy). Sometimes, nerves that connect to muscles atrophy (neurogenic atrophy), leading to loss of muscle mass and impaired movement. Individuals with McLeod neuroacanthocytosis syndrome may also have reduced sensation and weakness in their arms and legs (peripheral neuropathy). Life-threatening heart problems such as irregular heartbeats (arrhythmia) and a weakened and enlarged heart (dilated cardiomyopathy) are common in individuals with this disorder. The signs and symptoms of McLeod neuroacanthocytosis syndrome usually begin in mid-adulthood. Behavioral changes, such as lack of self-restraint, the inability to take care of oneself, anxiety, depression, and changes in personality may be the first signs of this condition. While these behavioral changes are typically not progressive, the movement and muscle problems and intellectual impairments tend to worsen with age.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10731\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"mcleod-neuroacanthocytosis","sourceDocuments":[{"name":"GARD: McLeod neuroacanthocytosis syndrome","reviewed":null,"source_release":"2026-10-21T16:59:09Z","url":"https://rarediseases.info.nih.gov/diseases/10731"},{"name":"MONDO: XK-related neurodegenerative disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018945"}],"sourceNote":"","synonyms":["MCLDS","McLeod neuroacanthocytosis syndrome","McLeod syndrome","MLS","X-linked McLeod syndrome","XK disease"],"takeawayHtml":"","title":"XK-related neurodegenerative disease"},"schemaVersion":1}
